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Objectives: To compare the three non-steroidal anti-inflammatory agents (NSAIDs) diclofenac potassium, etodol-
ac and naproxen sodium in relation to pain, swelling and trismus following impacted third molar surgery.
Study Design: The study was a randomized and a double-blinded study which included 42 healthy young individu-
als with impacted third molars and bone retention. Patients were randomly assigned to 3 groups (n: 14) to which 
diclofenac potassium, naproxen sodium and etodolac were administered orally an hour before the operation. Im-
pacted third molars were surgically extracted with local anaesthesia. Visual analog scales (VAS) were used to 
assess the pain in the 6th, 12th hours and on the 1st, 2nd, 3rd, 5th, and 7th days postoperatively. Swelling was evaluated 
using ultrasound (US) and mouth opening (trismus) was measured with a composing stick pre and post operatively 
on the 2nd and 7th days respectively. 
Results: Regarding pain alleviation, diclofenac potassium was better than naproxen sodium and naproxen sodium 
was better than etodolac but these differences were not statistically significant. US measurements showed that the 
swelling on postoperative 2nd day was significantly lowest with diclofenac potassium as compared to others (p= 
0.027) while naproxen sodium and etodolac acted similarly (p=0.747). No difference was noted regarding trismus 
in any of the groups.
Conclusions: NSAIDs (diclofenac, naproxen and etodolac) are somehow similarly effective for controlling pain 
and trismus following extraction of mandibular third molars but diclofenac potassium surpasses others in reduc-
tion of swelling. 
Key words: Diclofenac potassium, naproxen sodium, etodolac, impacted third molar surgery, pain, swelling, 
trismus.
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The surgical removal of impacted third molars is one 
of the most frequently performed procedures in oral 
surgery and afterwards complications such as post-
operative pain, swelling and trismus may occur (1). As 
prostaglandins are presumed to be primary mediator 
of acute postsurgical inflammatory changes, these pa-
tients, therefore are ideal clinical subjects to study the 
effect of anti-inflammatory agents on sequelae of teeth 
extractions such as pain, edema and trismus (2). 
Non-steroidal anti-inflammatory drugs (NSAIDs) are 
regarded as effective medications in the management of 
pain and other discomforts associated with oral surgery 
and exert their therapeutic effect through inhibition of 
cyclooxygenase (COX), which inhibits prostaglandin 
production whose synergistic interactions with other 
mediators promote local inflammatory reactions and 
hyperalgesia. Traditionally, two isoforms of COX are 
known: COX-1, a constitutive form expressed in almost 
all tissues which is responsible for the routine physi-
ological functions of prostanoids, including gastric mu-
cosal protection and vascular homeostasis and COX-2, 
which is found in a limited number of tissues such as 
kidney, prostate and brain which is primarily respon-
sible for the synthesis of prostanoids and mediation of 
responses to pathological processes, such as inflamma-
tion, pain and fever (2-4). Naproxen sodium, diclofenac 
potassium and etodolac have both COX-1 and COX-2 
inhibitory effects (4).
Naproxen sodium is a propionic acid derivative mainly 
used in osteoarthritis and rheumatoid arthritis and is 
also used as an anti-pyretic and anti-analgesic agent. 
Naproxen sodium is a NSAID that is traditionally orally 
administered and the usual doses for oral surgical pro-
cedures range between 275 and 550mg (5).  
Diclofenac potassium is a NSAID that is either available 
as an immediate release oral potassium salt tablet form, 
or as a delayed-release sodium salt tablet form. Many 
studies showed efficacy of diclofenac as compared to 
other NSAIDs in management of acute pain follow-
ing third molar surgery and other dental surgical pro-
cedures. As an analgesic and anti-inflammatory agent, 
diclofenac dose ranges between 25 and 100 mg po for 
oral surgical procedures (6-9).
Etodolac is a NSAID that is in acetic acid preparation 
form which is used in treating various acute and chronic 
musculoskeletal conditions, including osteoarthritis of 
all joints (10). Earlier studies have reported that etodo-
lac in 50 to 400 mg/day po doses provides dose-related 
relief of moderate to severe postoperative pain from a 
variety of surgical and dental procedures (11). 
Non-steroidal anti-inflammatory drugs (NSAIDs), when 
administered pre-operatively, can be absorbed and dis-
tributed to oral tissues before the initiation of surgical 
trauma, thus ensuring a blockade of arachidonic acid 
pathway, with subsequent reduction in the occurrence 
of post-operative swelling, trismus, discomfort and pain 
(12).
The objective of this study is to compare the preemptive 
administration of diclofenac potassium and etodolac 
and naproxen sodium on postoperative management 
of pain, swelling and trismus following removal of im-
pacted mandibular third molars.
Material and Methods
A clinical, randomized and double-blinded study which 
included 42 patients was carried out.  Healthy outpa-
tients of either gender, between the ages of 17 and 25 
years, who presented to the Oral and Maxillofacial Sur-
gery Clinics for surgical removal of mandibular third 
molars were included in the study. This study lasted 
a year and a half. The trial was conducted in accord-
ance with the standards of Good Clinical Practices for 
NSAIDs drugs and guidelines of the Helsinki Declara-
tion on human subjects. Also the local Institutional Re-
view Board approved the design of the study. Exclusion 
criteria were hepatic or renal disease, blood dyscrasias, 
gastric ulcer, heart disease, known hypersensitivities, 
allergies or reactions to any of the study medications, 
pregnancy and lactation. In addition, patients who had 
taken any drug within last month before surgery were 
excluded from the study.
The study protocol was explained to all patients in de-
tail and written informed consent was obtained. Pa-
tients were randomly allocated into three groups in a 
double -blinded fashion by using a prepared drug box 
with three compartments coded A (etodolac group), B 
(naproxen sodium group) and C (diclofenac potassium 
group) and each drug was  handed as a coated tablet to 
patients 1 hour before the operations by the auxiliary 
personnel. In summary; a total of 42 patients were ran-
domly allocated into 3 groups of 14 third molar teeth as 
mentioned above (A, B and C groups).
Patients in group A were given etodolac (Tadolak 200 
mg tablet, Saba Drug Industries, Turkey). Group B re-
ceived naproxen sodium (Apranax 275 mg tablet, Abdi 
İbrahim Drug Industries, Turkey) and group C was ad-
ministered diclofenac potassium (Cataflam 50 mg ta-
blet, Novartis Pharma AG, Switzerland).
The degree of surgical difficulty of impacted third mo-
lars was assessed using Archers Classification (Class I 
and II). Vertical or mesio angulation and bony reten-
tion were taken into consideration. Oral perioperative 
antibiotics (500 mg amoxicilin, Alfoxil 500 mg tablet 
Abfar Drug Industries, Turkey), were administered to 
all patients 1 hour before the surgery also chlorhexidine 
gluconate 0.2% (Klorhex Mouthwash, 200ML, Drogsan 
Drug Industries, Turkey) was given to all patients as 
mouth wash. On the following day after surgery, rescue 
analgesic (Paracatemol 500 mg, Parol tablet, Atabay 
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Drug Industries, Turkey) was made available to all pa-
tients for use if needed.
- Surgical procedure
Surgery of the impacted third molars was carried out 
under local anaesthesia (2% Articain hydrochloride 
with 1:100.000 adrenaline) with buccal guttering tech-
nique after adequate elevation and reflection of buccal 
mucoperiosteal flap. Tooth delivery was followed by 
meticulous irrigation of the surgical site with physi-
ologic saline (0,9 %). The three-sided muco-periosteal 
flap was repositioned and sutured. A single experienced 
surgeon performed the all surgical procedures. If op-
eration times exceeded 30 minutes, those patients were 
excluded from the study.
- Measurement of Pain Intensity 
Perioperative pain was assessed using Visual Analogue 
Scale (VAS). Accordingly, pain was recorded as: ‘no 
pain’ (no discomfort, VAS: 0), ‘mild pain’ (almost un-
noticeable pain, VAS: 1-2), ‘moderate pain’ (noticeable 
pain but patient can engage in routine daily activities, 
VAS:3-4), ‘heavy pain’ (very noticeable pain but patient 
can engage in routine daily activities, VAS: 5-6), ‘se-
vere pain’ (significant pain, patient can perform daily 
activities, VAS:7-8) and ‘intolerable pain’ (patient can-
not perform their daily activities and has to take rescue 
analgesic medication, VAS:9-10). For each patient, the 
subjective appropriate score was recorded by a ques-
tionnaire at 6th, 12th hours and on 1st, 2nd, 3rd, 4th, 5th 
and 7th days postoperatively. Before leaving the clinic, 
the surgeon ensured that all patients were thoroughly 
instructed on how to complete the pain self-assessment 
diary and when to take medications.
- Measurement of swelling
The facial swelling was measured quantitatively in mi-
limeters (mm) using ultrasound (US). Ultrasonographic 
measurements were carried out preoperatively and 
postoperatively at second and seventh days by single 
experienced radiologist. The ultrasound examinations 
were performed using linear 12 MHz probes (Toshiba 
SSA-770A/80, Aplio, Japan). The patients were placed 
in supine position and their faces were slightly turned 
to the contralateral side. The probe was placed trans-
versely on the buccal space and short axis images were 
obtained. The anterior border of the ramus of the man-
dible and anterior border of the masseter muscle was 
used as reference landmarks for standardization of 
measurements. The probe was oriented transversely so 
that the cortex of ramus of mandibula lied as a defini-
tive echogenic horizontal line posteriorly on the image 
screen. Then the vertical distance from the skin to this 
echogenic line was measured. Measurements were done 
on the screen after freezing the optimal image and ob-
taining three consecutive measurements. The median 
value was recorded and registered to the closest 0.1 
mm. Both sides were measured in the same manner. 
This distance encompassed the skin and the buccal fat 
pad. This anatomic area was markedly affected by the 
edema and hemorrhage caused by tooth extraction. Pa-
tients were instructed to close their mouths and contact 
the upper and lower teeth in a natural relaxed way that 
maintained light interocclusal contact and told not to 
forcefully clench the jaw, teeth or masticatory muscles 
during measurements. Care was taken to avoid com-
pression of buccal space. 
- Measurement of maximum mouth opening ability 
(Trismus)
Mouth opening ability was measured in millimetres 
(mm) with a regular composing stick preoperatively 
and postoperatively at second and seventh postoperative 
days. The incisal edge of the maxillary central teeth and 
incisal edge of mandibular central teeth were used as 
reference points at the most available maximum mouth 
opening.
- Statistical Analysis
Data analysis was carried out using commercially avail-
able software (Statistical Package for Social Sciences, 
SPSS for Windows 15.0, Inc, Chicago, Illinois, USA). 
Comparison of the independent drug groups were car-
ried out using ‘Kruskal Wallis Test’. Double compari-
sons of the groups were done with ‘Mann-Whitney U 
Test’. Multiple comparisons of the data from different 
related times among drug groups were calculated using 
‘Friedman Test’ and double comparisons of the same 
data were studied with ‘Wilcoxon Signed Ranks Test’. 
The level of significance was set at P<0.05.
Results
A total of 42 patients (14 male and 28 female; age rang-
ing from 18 to 25 year; mean age, 20.8± 4.1 year), who 
had impacted molars which were Class I or Class II and 
in vertical or mesio-angular positions as described in 
Archer’s Impacted Third Molar Classification (Fig. 1) 
were included in this study. The study was carried out 
in a prospective, randomized and double-blinded man-
ner.
Fig. 1. A panoramic roentgen of a patient (MD) operated for removal 
of mandibular third molars. The classifications of third molars were 
compatible with Class II, in Mesio-Angular position according to 
Archer Third Molar Classification.
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The average surgery time was 21.5 minutes. No adverse 
effects or complications related to surgery were record-
ed in any treatment group throughout the study period. 
No alterations of the mandibular nerve conductivity 
were recorded. The lip and cheek sensitivity returned 
to normal in all patients within 2 to 4 hours postopera-
tively. 
- Postoperative pain assessment
Collected pain data was assessed with descriptive, mul-
tiple and double comparative statistical analysis. All 
drug groups (Etodolac-A, Naproxen Sodium-B and 
Diclofenac Potassium-C) were compared with each 
other for pain intensity at predetermined times by us-
ing Kruskal Wallis Test (Table 1) and results were not 
statistically significant (P>.05).
The efficacy of drugs on pain according to time course 
was also shown graphically in figure 2. Diclofenac 
potassium appeared to be the most effective of all in 
this regard but results were not statistically significant 
(P>.05).
- Postoperative swelling assessment
Differences among groups were compared using 
‘Kruskal Wallis Test in terms of efficacy on swelling 
(Table 2). Results showed that;
1- There was no significant difference between the 
drug groups at preoperative and postoperative 7th days 
(P>.05). 
2- Signifi cant differences were detected at postopera-
tive 2th day in terms of efficacy on swelling (P<.05).
Double comparison of drug groups was performed by us-
ing ‘Mann-Whiney U Test’ at 2th day. Results showed that:
1- When Etodolac and Naproxen sodium were com-
pared, in terms of efficacy on swelling, there was no 
significant difference (P=, 747).   
2- Diclofenac potassium was signifi cantly more effec-
tive on swelling than Etodolac and Naproxen sodium 
respectively (P=.027) (P=.020).
The efficacy of drug groups on swelling according to 
time courses was shown graphically in fi gure 3. Di-
clofenac potassium was more effective than etodolac 
and naproxen sodium and this effect was most signifi-
cant at postoperative 2th day (P<.05).
- Postoperative mouth opening ability (Trismus) assess-
ment
Mouth opening ability was used to denote trismus and 
decreased postoperatively. Results (Kruskal Wallis test) 
Time Drugs Mean±Std (Min-Max) P
6th hour 
A (n:14) 4.43±2.10 (0-8) 
0.472
B (n:14) 3.57±2.24 (0-6) 
C (n:14) 3.57±2.24 (0-8) 
Total n:42 3.86±2.18 (0-8) 
12th hour
A (n:14) 2.14±1.65 (0-4) 
0.074
B (n:14) 2.86±1.51 (0-6) 
C (n:14) 1.43±1.45 (0-4) 
Total n:42 2.14±1.61 (0-6) 
24th hour
A (n:14) 1.71±1.06 (0-4) 
0.062
B (n:14) 1.29±1.26 (0-4) 
C (n:14) 0.71±1.26 (0-4) 
Total n:42 1.24±1.24 (0-4) 
48th hour
A (n:14) 0.57±0.93 (0-2) 
0.189
B (n:14) 0.71±0.99 (0-2) 
C (n:14) 0.14±0.53 (0-2) 
Total n:42 0.48±0.82 (0-2) 
72th hour
A (n:14) 0.14±0.53 (0-2) 
0.054
B (n:14) 0.71±1.26 (0-4) 
C (n:14) 0.00±0.00 (0-0) 
Total n:42 0.29±0.83 (0-4) 
Day 5 
A (n:14) 0.14±0.53 (0-2) 
0.349
B (n:14) 0.29±0.72 (0-2) 
C (n:14) 0.00±0.00 (0-0) 
Total n:42 0.14±0.51 (0-2) 
Day7 
A (n:14) 0.00±0.00 (0-0) 
0.368
B (n:14) 0.14±0.53 (0-2) 
C (n:14) 0.00±0.00 (0-0) 
Total n:42 0.05±0.30 (0-2) 
Table 1. Postoperative pain intensity values measured by 
VAS (Visual analogue scale) post surgery (postoperative 
6th hour to day 7). A: Etodolac, B: Naproxen Sodium, C: 
Diclofenac Potassium, n: Number of subjects, Std: Standart 
deviation, Min: Minimum, Max: Maximum. 
Time Drugs Mean±Std (Min-Max) 
         
    P 
Preoperative
A (n:14) 4.31±1.18 (2.9-6.7) 
0.567 
B (n:14) 4.67±1.33 (3.1-7.2) 
C (n:14) 4.14±1.15 (2.6-6.5) 
Total n:42 4.37±1.21 (2.6-7.2) 
2nd day 
A (n:14) 9.60±3.36 (4.3-17.3) 
0.031 
B (n:14) 9.29±2.52 (6.2-13.9) 
C (n:14) 7.30±2.36 (4.8-12.9) 
Total n:42 8.73±2.90 (4.3-17.3) 
7th day 
A (n:14) 4.50±1.70 (2.6-9.5) 
0.763 
B (n:14) 5.05±2.19 (2.8-10.0) 
C (n:14) 4.37±0.83 (3.3-6.2) 
Total n:42 4.64±1.66 (2.6-10.0) 
Table 2. Postoperative edema measured by ultrasound (buccal 
area thickness in milimeters) preoperatively, on the 2nd day and 
on the 7th day following molar surgery A: Etodolac, B: Naprox-
en Sodium, C: Diclofenac Potassium, n: Number of subjects, 
Std: Standart deviation, Min: Minimum, Max: Maximum.
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showed that there were no statistical differences between 
the drug groups regarding trismus (P>.05) (Table 3). 
The efficacy of drugs on mouth opening ability accord-
ing to the postoperative time course was also graphi-
cally shown (Fig. 4). Results showed that diclofenac po-
tassium was more effective than etodolac and naproxen 
sodium. However findings were not statistically signifi-
cant as mentioned above (P>.05).
None of the patients in any of the groups used the res-
cue analgesic although it was made available to them. 
No major or minor complications related to medications 
were encountered in any of the groups. 
Fig. 2. The efficacies of drugs on pain depicted in a time course.
Fig. 3. Graphic shows the efficacies of drugs on swelling versus time.




In the present study, the efficacy of NSAIDs which were 
diclofenac potassium, naproxen sodium and etodolac 
were investigated in regards to pain, swelling and tris-
mus following third molar surgery. To our knowledge, 
there is no comparative study comparing these three 
drugs on this subject.  
Close relation between postoperative complications 
(pain,swelling and trismus) and operation time was 
shown in various studies (13). In the present study, any 
third molar operation that exceeded 30 minutes was ex-
cluded from the study. If there was any deviation from the 
surgical technique described in the material and methods 
section due to difficulties in extraction, these patients 
were excluded as well. 
Timing of NSAID administration is a subject of debate. 
Some authors favour preoperative medication arguing 
that it allows better postoperative analgesia control by 
suppression of peripheral and central sensitization while 
others argue that preemptive medication performs less 
compared to postoperative administration of the same 
drugs (12).  In the study by Bridgman et al. diclofenac 
sodium did not demonstrate any significant pre-emptive 
analgesic effects (14). On the contrary Shah et al. com-
pared the analgesic effect of diclofenac sodium before 
and after third impacted molar surgery and suggested 
that preemptive medication provides better pain control 
(15). The findings in our study also support the notion to 
administer drugs preoperatively. 
In this study, diclofenac potassium was slightly more ef-
fective on postoperative pain but the difference between 
Time Drugs Mean±Std (Min-Max) 
     
     P 
Preoperative
A (n:14) 46.50±3.85 (39-52) 
0.285 
B (n:14) 48.36±3.02(42-52) 
C (n:14) 46.50±3.43(42-53) 
Total n:42 47.12±3.48 (39-53) 
2nd day 
A (n:14) 32.71±4.71 (25-43) 
0.704 
B (n:14) 33.50±7.16 (19-44) 
C (n:14) 31.86±5.92 (24-43) 
Total n:42 32.69±5.90 (19-44) 
7th day 
A (n:14) 41.96±4.47 (33-48) 
0.962 
B (n:14) 41.21±5.19 (32-47) 
C (n:14) 39.64±9.71 (15-52) 
Total n:42 40.90±6.76 (15-52) 
Table 3. Postoperative trismus measurements (mouth opening) 
in milimeters preoperatively, on the 2nd day and on the 7th day 
following molar surgery. A: Etodolac, B: Naproxen Sodium, C: 
Diclofenac Potassium,  n: Number of subjects, Std: Standart de-
viation, Min: Minimum, Max: Maximum. 
Fig. 4. The efficacies of drugs on average trismus values presented over a 
time course. 
diclofenac, etodolac and naproxen regarding pain in any 
postoperative time period was not statistically signifi-
cant (Fig. 2).  Oncul et al. compared preoperative IV di-
clofenac sodium with IV paracetamol (acetaminophen) 
and Lornoxicam and concluded that although all were 
equally effective on postoperative pain (16). Diclofenac 
was reported to be better in controlling postoperative 
pain compared to tramadol and ketorolac but less com-
pared to piroxicam and nimesulid and tenoxicam (17-21).
There are only a few studies about the efficacy of 
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Etodolac on molar teeth extraction surgery. Etodolac 
performed better compared to placebo and showed sim-
ilar efficacy compared to aspirin (22), acetaminophen 
plus codeine combination and zomepirac regarding 
postoperative pain but performed less compared to dif-
lunisal (23,24).
Combination of NSAID’s with steroids appears to be 
more effective in controlling complications after third 
molar surgery as compared to NSAID’s alone espe-
cially regarding pain and swelling, but carry a certain 
risk of adversity such as adrenal suppression and con-
cerns about impaired wound healing, therefore their 
routine use has not been justified (8). Bamgbose et al. 
compared co-administration of dexamethasone and di-
clofenac potassium with diclofenac potassium alone. 
They concluded that co-administration was more effec-
tive as compared to diclofenac potassium alone for pain 
and swelling but no significant difference was noted 
regarding trismus (8). Likewise, Lopez-Carriches et al. 
compared diclofenac to metilprednisolone and steroids 
slightly performed better in pain reduction and swelling 
but not in trismus (9). 
Bjørnsson et al. compared naproxen and acetaminophen 
on postoperative sequelae after impacted third molar 
surgery. They found that naproxen was more effec-
tive on pain than acetaminophen, but acetaminophen 
was more effective on swelling than naproxen (5). In 
the present study diclofenac appeared more effective on 
swelling than naproxen. When acetaminophen and di-
clofenac are compared, they were reported to have simi-
lar efficacy (16,25). Acetaminophen is considered safer 
and combination with diclofenac is reported to perform 
better compared to diclofenac alone and acetaminophen 
codeine combination (25,26).
Several methods were employed to measure postop-
erative swelling including VAS, stereophotography, su-
tures and face-bow (13,27-29). Ultrasound method was 
utilized in a few studies and reported to be an effica-
cious method of measurement and as good as CT (30). 
Ultrasound was used this study to measure postopera-
tive swelling (Fig. 5-7).
In the present study, there were no differences between 
the drug groups on postoperative mouth opening abil-
ity (trismus). If the time courses are surveyed in the 
present study, a little advanced effect of diclofenac may 
be encountered as compared to other drugs but the dif-
ference was not statistically significant. Many studies 
support the present study in terms of mouth opening 
ability (5,8). 
In conclusion, in the present study; diclofenac potas-
sium performed significantly better on swelling and as 
good as other two drugs naproxen sodium and etodolac 
regarding pain and trismus. In other words, the present 
study aligned the drugs as diclofanac potassium> 
naproxen sodium = etodolac in terms of reducing the 
Fig. 5. Evolution of postoperative swelling. Preoperatively right buc-
cal thickness measures 4,7 mm. 
Fig. 6. Measurement on 2nd postoperative day reveals marked soft 
tissue swelling of 10,8 mm.
Fig. 7. Measurement on 7th postoperative day showed that the soft 
tissue swelling has regressed markedly back to 4.5 mm. 
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postoperative third molar surgery sequelae. Various 
methods, such as different NSAIDs, laser, steroids etc. 
were tested and will continue to be tested on this issue. 
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